Under the terms of the agreement Boule Diagnostics will have exclusive rights to distribute VitalScientific’s clinical chemistry analyzers and associated consumables throughout the United States. When fully implemented this agreement will add estimated sales of SEK 20 million with an attractive margin.

“We are excited to partner with VitalScientific, a company that shares our commitment to quality and innovation and brings more than 20 years of experience servicing Physician Office Labs (POL), clinics and small reference labs for the US market,” says Torben Nielsen, CEO of Boule Diagnostics. “This agreement marks a significant milestone in our efforts to expand our footprint in the US market and provide healthcare professionals with a broader range of reliable and efficient diagnostic solutions.”

Fully implemented in the second half of 2025

The implementation of this exclusive distribution agreement will commence immediately, with both companies working closely to ensure a seamless transition and uninterrupted supply of products to the market. They expect the agreement to be fully implemented in the second half of 2025.